N. Ikegaya et al., CORRELATION BETWEEN HISTOLOGIC FEATURES AND GLOMERULAR-PERMEABILITY IN MEMBRANOUS NEPHROPATHY AND IMMUNOGLOBULIN-A NEPHROPATHY, The Journal of laboratory and clinical medicine, 123(1), 1994, pp. 94-101
Citations number
41
Categorie Soggetti
Medical Laboratory Technology","Medicine, General & Internal
We evaluated the correlation between histologic features and glomerula
r permselectivity based on fractional clearances of dextrans relative
to inulin (FCsDex). The subjects consisted of 12 healthy volunteers, 1
8 patients with membranous nephropathy, and 20 patients with immunoglo
bulin A nephropathy. In membranous nephropathy, FCsDex measured with l
arge dextrans (radii larger than 56 Angstrom) increased as the capilla
ry lesion progressed. Histologic examination showed that glomerular ca
pillary alteration was the factor most closely linked to changes in FC
sDex in membranous nephropathy. Proteinuria (normalized to glomerular
filtration rate) did not correlate with FCsDex. Increased FCsDex tende
d to normalize during prednisolone treatment in membranous nephropathy
. In immunoglobulin A nephropathy, the impairment of glomerular size s
electivity depended on the degree of mesangial sclerosis and tubuloint
erstitial injury. FCs of dextrans of 59 Angstrom were correlated with
the mesangial sclerosis index (r = 0.573, p = 0.050) and the tubuloint
erstitial injury index (r = 0.707, p 0.003). Proteinuria (again normal
ized to glomerular filtration rate) was significantly correlated with
FCs of large dextrans in immunoglobulin A nephropathy (r = 0.668, p =
0.008). We conclude that glomerular size-selective barriers were impai
red both in membranous nephropathy and immunoglobulin A nephropathy. H
owever, the mechanisms of impaired size selectivity might differ, at l
east in part, between these nephropathies. The predominant factors res
ponsible for the size-selective defect seemed to be glomerular capilla
ry wall lesions in membranous nephropathy but mesangial sclerosis or t
ubulointerstitial damages (or both) in immunoglobulin A nephropathy.